| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |